Elon Musk’s brain-computer interface company, Neuralink, has successfully closed a $650 million Series E funding round, according to an announcement made by the startup on Monday. Leading investors contributing to this capital raise include ARK Invest, Founders Fund, Sequoia Capital, and Thrive Capital, among others.
The latest funding represents significant growth compared to Neuralink’s previous Series D funding round in 2023, which brought in $280 million, along with an additional $43 million secured shortly thereafter. Neuralink has since made notable advancements in its brain chip technology.
The company revealed that it has now implanted its neurological devices into five individuals experiencing severe paralysis in expanded human clinical trials. These developments follow Neuralink’s recent receipt of a “breakthrough device” designation from the U.S. Food and Drug Administration (FDA) in May, which expedites regulatory review processes designed to accelerate innovative medical technologies to market.
Recent reports indicate that the latest investment round places Neuralink’s valuation at approximately $9 billion pre-money.
